Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Argentina Makes An Official Announcement Of The COVID-19 Vaccine Supply Deal…
Atossa Therapeutics Inc (NASDAQ: ATOS) Granted Regulatory Approval To Open Clinical…
Sorrento Therapeutics Inc (NASDAQ: SRNE), Receives FDA Nod For Clinical Study…
Sigilon Therapeutics Inc (NASDAQ: SGTX) Phase 1/22 Study of SIG-OO1 Placed…
Galectin Therapeutics Inc. (NASDAQ: GALT) Announces Results From Phase 1b Clinical…
Finance
Brooklyn Immunotherapeutics Inc (NYSEAMERICAN:BTX) Clinches An Exclusive License mRNA Gene Editing…
Amarin Corporation Plc (NASDAQ:AMRN) Receives Marketing Authorization For Icosapent Ethyl From…
Hollywall Entertainment Inc (OTCMKTS:HWAL): Under-the-Radar NFT Star in the Making? (PLBY,…
GeoVax Labs (GOVX) surges on positive sentiment
Compass Pathways (CMPS) could lead psychedelic sector
Tech News
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
Amarin Corporation Plc (NASDAQ:AMRN)
Tag: Amarin Corporation Plc (NASDAQ:AMRN)
Amarin Corporation Plc (NASDAQ:AMRN) Will Commercialize VAZKEPA In Q3 2021: Reports...
Kate Hudson
-
May 7, 2021
0
Amarin Corporation Plc (NASDAQ:AMRN) Receives Marketing Authorization For Icosapent Ethyl From...
Gavins Felicity
-
April 23, 2021
0
Amarin Corporation plc (NASDAQ:AMRN) Presents VASCEPA® Clinical Study Findings At The...
Matt Wade
-
February 3, 2021
0
Amarin Corporation plc (NASDAQ:AMRN) Announces Q3 Results As VASCEPA Continues To...
Gavins Felicity
-
November 11, 2020
0
Amarin (NASDAQ:AMRN)Established That VASCEPA® can Reduce Ischemic Events In Individuals That...
Kate Hudson
-
October 28, 2020
0
Amarin Corporation plc (NASDAQ:AMRN) Supported New Data from Clinical Research Evaluating...
Ward Sport
-
September 7, 2020
0
Amarin Corporation Plc (NASDAQ:AMRN) Reports A Growth Of 34% YoY In...
Matt Wade
-
August 24, 2020
0
Amarin Corporation plc (NASDAQ:AMRN) says it is Supporting Investigator-Initiated Trial Evaluating...
Ward Sport
-
August 19, 2020
0
Data from the REDUCE-IT® REVASC Analysis Presented by Amarin Corporation plc....
Gavins Felicity
-
August 14, 2020
0
Amarin Corporation Plc (NASDAQ:AMRN) Reaches Settlement With Apotex Regarding Generic VASCEPA
Kate Hudson
-
June 26, 2020
0
.td-post-views{ display: none !important; }
